RETRACTED: Inhibition of Multiple Protective Signaling Pathways and Ad.5/3 Delivery Enhances mda-7/IL-24 Therapy of Malignant Glioma
Open Access
- 1 June 2010
- journal article
- retracted article
- Published by Elsevier in Molecular Therapy
- Vol. 18 (6) , 1130-1142
- https://doi.org/10.1038/mt.2010.29
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cellsThe Prostate, 2009
- A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cellsCancer Chemotherapy and Pharmacology, 2009
- MDA-7/IL-24–induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK–dependent mechanismMolecular Cancer Therapeutics, 2009
- Synergistic combinations of signaling pathway inhibitors: Mechanisms for improved cancer therapyDrug Resistance Updates, 2009
- ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy MachineryMolecular Biology of the Cell, 2009
- Multiple Cyclin Kinase Inhibitors Promote Bile Acid-induced Apoptosis and Autophagy in Primary Hepatocytes via p53-CD95-dependent SignalingJournal of Biological Chemistry, 2008
- Autocrine regulation of mda -7/IL-24 mediates cancer-specific apoptosisProceedings of the National Academy of Sciences, 2008
- Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cellsMolecular Cancer Therapeutics, 2008
- Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): Novel gene therapeutic for metastatic melanomaToxicology and Applied Pharmacology, 2007
- c-Jun N-terminal Kinase Is Essential for Growth of Human T98G Glioblastoma CellsPublished by Elsevier ,2000